Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenrong Bian Wan is a traditional Chinese medicine (TCM) developed and manufactured by Guiyang Dechangxiang Pharmaceutical. It is an approved pharmaceutical product in China, primarily indicated for the treatment of kidney yang deficiency, which manifests as impotence, premature ejaculation, sexual dysfunction, and general fatigue. The formulation is a complex combination of herbal and animal-derived ingredients, including ginseng, deer antler velvet, and various animal penises (such as those from dogs, donkeys, and minks). These components are traditionally believed to work synergistically to tonify the kidneys, replenish essence (Jing), and strengthen the yang energy, thereby improving male reproductive health and overall vitality. It is typically administered orally in the form of water-honeyed pills.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shenrong bian wan.